CLOSE FTSE TECHMARK X

A technology index tracker covering UK listed companies only.

  • 230.50p Price (Inc)
  • - Price (Acc)
  • 0.00% 0.00%

    Initial charge
  • 0.45% Annual management charge
  • 0.70% Ongoing charges
  • 1.30% Yield

Prices as at 01 January 2002 , fund data last updated 21 October 2019

The investment objective of the Fund is to track the FTSE techMark Focus Index performance in capital terms.

Fund summary

Sector Technology and Telecoms
Structure UNIT TRUST
Launched October, 2012
Size £39m
Yield 1.30%
Charging basis Income
Dividends paid Acc units only

Charges

Initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 0.45%
Ongoing charges figure 0.70%

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Investment process

The objective is to track the performance of the FTSE techMARK 100 index of LSE-listed technology stocks. The index was launched in November 1999 and includes small and medium sized companies - indeed, the techMARK 100 is a subset of the wider FTSE techMARK universe, being the the largest 100 companies but with a market cap of less than £4billion and above £100million. These young companies are characterised by their expertise and involvement in leading edge technology, such as biotechnology, Internet, software development and telecommunications.

Manager research

Average monthly relative returns

Bestinvest MRI

14/15 15/16 16/17 17/18 18/19 3 years 5 years Career 3 years 5 years Career
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Track record

Periods of worst performance

Absolute 0.00% ()
Relative 0.00% ()

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Top 10 holdings

Data accurate as at 30 June 2019

9.73% Smith & Nephew
9.71% Bae Systems
7.86% Sage Group
6.81% Micro Focus International
5.86% Flutter Entertainment Plc
5.04% Aveva Group
4.31% Genus
4.08% Spectris
3.94% Ultra Electronics Hldgs
3.8% Renishaw Plc
Source: Trustnet

Sector breakdown

Industrials 36.00%
Technology 33.00%
Health Care 23.00%
Others 6.00%
Telecommunications 2.00%

Portfolio

The portfolio replicates the techMARK 100 and therefore holds around 100 stocks.

Key Investor Documents

Download